As expected, the ECAR increased in control cells in response to oligomycin treatment indicating a shift to ATP production through glycolysis (Figure 1E), which is dramatically reduced in lymphoblasts derived from sporadic or SOD1-mutations carriers ALS patients. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.